FLVCR2 and cancer: CCT subunits were identified as part of the p53 interactome (Coffill et al., 2012) and immunoprecipitants of CCT1 (TCP-1) or CCT5 with wild-type or mutant forms of p53 were detected in cancer cells overexpressing the p53 constructs (Trinidad et al., 2013).